title: Management of cancerization field with a medical device containing photolyase: a randomized, double-blind, parallel-group pilot study.
authors.affiliation: Dermatology and Skin Cancer Unit, Arcispedale Santa Maria Nuova IRCCS, Reggio Emilia, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Moscarella
authors.affiliation: Dermatology Unit, Second University of Naples, Naples, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Argenziano
authors.affiliation: Dermatology and Skin Cancer Unit, Arcispedale Santa Maria Nuova IRCCS, Reggio Emilia, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Longo
authors.affiliation: ISDIN R&D, Barcelona, Spain.
authors.forename: S
authors.initials: S
authors.lastname: Aladren
mesh_terms: D000368:Aged; D004255:Deoxyribodipyrimidine Photo-Lyase / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D055623:Keratosis, Actinic / Q000188:drug therapy*; D008297:Male; D010865:Pilot Projects; D011446:Prospective Studies; D012878:Skin Neoplasms / Q000517:prevention & control; D013473:Sunscreening Agents / Q000627:therapeutic use*
chemical_list: D013473:Sunscreening Agents; D004255:Deoxyribodipyrimidine Photo-Lyase; C000633124:Eryfotona